The incorporation of traditional Ayurvedic botanicals with modern, patient-centric drug delivery systems offers significant potential for enhancing therapeutic compliance, particularly in the management of cognitive and neurological health. This review article outlines the development and evaluation framework for a novel polyherbal gummy formulation incorporating Bacopa monnieri (Brahmi) and Withania somnifera (Ashwagandha) as primary neuro-supportive agents, blended with Zingiber officinale (Ginger) and Cinnamomum verum (Cinnamon) to enhance bioavailability and provide supplementary antioxidant benefits. While conventional solid dosage forms often suffer from poor palatability and lower adherence among paediatric and geriatric populations, chewable medicated gummies offer a highly palatable, water-independent alternative. This paper comprehensively reviews the pharmacological profiles of the selected phytoconstituents, focusing specifically on their neuroprotective, anxiolytic, anti-inflammatory, and bioavailability-enhancing properties. Furthermore, it outlines a systematic, theoretical methodology for formulating these polyherbal gummies using a gelatin and agar-agar polymer matrix. The review also details standard quality control and evaluation parameters necessary for future empirical studies, including physical stability, moisture content, pH, syneresis, and in-vitro dispersion time. Ultimately, this approach bridges the gap between established polyherbal phytotherapy and modern nutraceutical delivery, providing a foundational blueprint for the future laboratory development and clinical evaluation of medicated gummies.